HIV-1 primary and secondary antiretrovir
✍
Ludimila Paula Vaz Cardoso; Gisner Alves Souza Pereira; Ângela Alves Viegas; Lui
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 148 KB
👁 1 views
## Abstract Antiretroviral (ARV) resistance mutations in HIV‐1 may reduce the efficacy of prophylactic therapy to mother‐to‐child transmission and impact future treatment options. ARV resistance mutations and HIV‐1 phylogenetic diversity in protease (PR) and reverse transcriptase (RT) genes were as